Asaf Danziger, Chief Executive Officer at NovoCure Ltd (NVCR), sold 177,390 shares at $47.48 ($8.4M) on 2019-01-23, disclosed to the SEC on 2019-01-25.
Open-market sale of $8.4M NVCR by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.48 | 88,695 | $4.2M | 50.0% |
| 2 | $47.48 | 88,695 | $4.2M | 50.0% |
| Total | $47.48 avg | 177,390 | $8.4M | 100% |
| Filing → |
| NVCR | SELL | 2021-04-15 | $38.5M | — | Filing → |
| NVCR | SELL | 2020-12-22 | $61.4M | — | Filing → |
| NVCR | SELL | 2020-09-17 | $10.2M | — | Filing → |